PD14-02 CENTERS FOR MEDICARE AND MEDICAID SERVICES' (CMS) HOSPITAL COMPARE STAR RANKINGS AND SHORT-TERM OUTCOMES AFTER MAJOR UROLOGICAL CANCER SURGERY

Le résumé fourni par la source

You have accessJournal of UrologyGeneral & Epidemiological Trends & Socioeconomics: Value of Care: Cost and Outcomes Measures I1 Apr 2017PD14-02 CENTERS FOR MEDICARE AND MEDICAID SERVICES' (CMS) HOSPITAL COMPARE STAR RANKINGS AND SHORT-TERM OUTCOMES AFTER MAJOR UROLOGICAL CANCER SURGERY Deborah R. Kaye, Chad Ellimootil, James M. Dupree, Zaojun Ye, Lindsey A. Herrel, Hye Sung Min, Edward C. Norton, and David C. Miller Deborah R. KayeDeborah R. Kaye More articles by this author , Chad EllimootilChad Ellimootil More articles by this author , James M. DupreeJames M. Dupree More articles by this author , Zaojun YeZaojun Ye More articles by this author , Lindsey A. HerrelLindsey A. Herrel More articles by this author , Hye Sung MinHye Sung Min More articles by this author , Edward C. NortonEdward C. Norton More articles by this author , and David C. MillerDavid C. Miller More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2017.02.703AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES In an effort to help patients identify high-quality hospitals, CMS recently released Hospital Compare, a 5-star hospital ranking system. We evaluated the relationship between CMS hospital star rankings and short-term outcomes after major urological cancer surgery. METHODS Using national Medicare claims and public-use files from the Hospital Compare program, we identified patients aged 66 to 99 who underwent a major prostate, bladder or kidney cancer surgery from January 1, 2011 through November 30, 2013. For each patient, we determined the CMS star rating (i.e., 1-5-star) for the hospital performing the surgery, as well as the occurrence of 30- day complications, mortality, readmissions, and/or prolonged length of stay. Hospital Compare excludes cancer specific quality measures in its methodology. We then performed univariable and multivariable analyses to examine the overall and procedure-specific associations between hospital star ratings and each surgical outcome. RESULTS We identified 122,321 patients undergoing prostate, bladder, or kidney cancer surgery at 2,147 hospitals rated in the Hospital Compare file. Five percent of hospitals were graded 1 star, 24% 2 stars, 44% 3 stars, 25% 4 stars and 3% 5 stars. For all three procedures combined, we identified a significant, inverse association between CMS star ranking and the occurrence of each adverse outcome (Figure 1). For instance, adjusted rates of readmission for 1- vs 5-star hospitals, were 11.3% and 8.1%, respectively (p=<0.001); likewise, rates of mortality at 1 and 5 star hospitals were 1.7% and 0.6%, respectively (p=<0.001). We identified similar relationships in separate procedure-specific analyses (Table 1). CONCLUSIONS Short-term outcomes after major urological cancer surgery are better for Medicare beneficiaries treated at hospitals with higher CMS Hospital Compare star ratings, suggesting a potential role for these rankings in guiding choice of hospitals. Additional research is needed, however, to determine if the star rankings accurately reflect other measures of quality in urological cancer care. © 2017FiguresReferencesRelatedDetails Volume 197Issue 4SApril 2017Page: e276-e277 Advertisement Copyright & Permissions© 2017MetricsAuthor Information Deborah R. Kaye More articles by this author Chad Ellimootil More articles by this author James M. Dupree More articles by this author Zaojun Ye More articles by this author Lindsey A. Herrel More articles by this author Hye Sung Min More articles by this author Edward C. Norton More articles by this author David C. Miller More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.